| |
| |
|
| Insider
Information: |
Gala Renee D |
| Relationship: |
President & COO |
| City: |
South San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
223,014 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$7,714,691 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
223,014 |
|
|
| Total
Value |
$7,714,691 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Theravance Biopharma, Inc. |
TBPH |
SVP, Chief Financial O... |
2018-11-20 |
157,657 |
2014-08-20 |
0 |
Premium* |
|
|
Corcept Therapeutics Inc |
CORT |
Director |
2018-03-07 |
10,000 |
2018-03-06 |
0 |
Premium* |
|
|
Jazz Pharmaceuticals Inc |
JAZZ |
President & COO |
2024-04-05 |
55,357 |
2020-05-07 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| JAZZ |
Jazz Pharmaceuticals Inc |
President & COO |
• – – |
2024-04-05 |
4 |
D |
$115.21 |
$200,005 |
D/D |
(1,736) |
55,357 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
President & COO |
• – – |
2024-03-05 |
4 |
D |
$117.53 |
$425,694 |
D/D |
(3,622) |
57,093 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
President & COO |
• – – |
2024-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
19,916 |
60,715 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
President & COO |
• – – |
2024-01-17 |
4 |
D |
$119.13 |
$381,693 |
D/D |
(3,204) |
40,799 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
President & COO |
• – – |
2024-01-17 |
4 |
A |
$0.00 |
$0 |
D/D |
7,079 |
44,003 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
President & COO |
• – – |
2023-11-10 |
4 |
A |
$0.00 |
$0 |
D/D |
772 |
36,887 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
EVP & Chief Financial Officer |
• – – |
2023-05-18 |
4 |
S |
$131.75 |
$790,474 |
D/D |
(6,000) |
35,978 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
EVP & Chief Financial Officer |
• – – |
2023-04-05 |
4 |
D |
$145.78 |
$263,424 |
D/D |
(1,807) |
41,978 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
EVP & Chief Financial Officer |
• – – |
2023-03-05 |
4 |
D |
$142.78 |
$222,308 |
D/D |
(1,557) |
43,785 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
EVP & Chief Financial Officer |
• – – |
2023-03-03 |
4 |
A |
$0.00 |
$0 |
D/D |
12,784 |
45,342 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
EVP & Chief Financial Officer |
• – – |
2022-12-21 |
4 |
AS |
$160.00 |
$421,600 |
D/D |
(2,635) |
32,558 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
EVP & CFO |
• – – |
2022-04-05 |
4 |
D |
$162.88 |
$265,983 |
D/D |
(1,633) |
34,995 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
EVP & CFO |
• – – |
2022-03-05 |
4 |
D |
$153.96 |
$110,851 |
D/D |
(720) |
36,628 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
EVP & CFO |
• – – |
2022-03-03 |
4 |
A |
$0.00 |
$0 |
D/D |
11,730 |
37,348 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
EVP & CFO |
• – – |
2021-04-05 |
4 |
D |
$164.71 |
$249,536 |
D/D |
(1,515) |
25,347 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
EVP & CFO |
• – – |
2021-02-25 |
4 |
A |
$0.00 |
$0 |
D/D |
10,115 |
26,862 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
EVP & CFO |
• – – |
2020-05-07 |
4 |
A |
$0.00 |
$0 |
D/D |
16,600 |
16,600 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
SVP, Chief Financial Officer |
• – – |
2018-11-20 |
4 |
D |
$24.79 |
$166,019 |
D/D |
(6,697) |
157,657 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
SVP, Chief Financial Officer |
• – – |
2018-08-20 |
4 |
D |
$26.95 |
$180,430 |
D/D |
(6,695) |
164,354 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
SVP, Chief Financial Officer |
• – – |
2018-08-15 |
4 |
S |
$26.71 |
$1,110,655 |
D/D |
(41,539) |
171,049 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
SVP, Chief Financial Officer |
• – – |
2018-08-14 |
4 |
S |
$27.74 |
$61,136 |
D/D |
(2,204) |
212,588 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
SVP, Chief Financial Officer |
• – – |
2018-05-20 |
4 |
D |
$24.31 |
$516,101 |
D/D |
(21,230) |
214,792 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
SVP, Chief Financial Officer |
• – – |
2018-05-18 |
4 |
S |
$24.29 |
$242,877 |
D/D |
(10,000) |
236,022 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
SVP, Chief Financial Officer |
• – – |
2018-05-14 |
4 |
A |
$0.00 |
$0 |
D/D |
33,750 |
246,022 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Director |
– • – |
2018-03-07 |
4 |
B |
$15.53 |
$139,802 |
D/D |
9,000 |
10,000 |
2.39 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
